BioXcel Therapeutics, Inc. (BTAI)

NASDAQ: BTAI · Real-Time Price · USD

1.430

-0.050 (-3.38%)

At close: May 13, 2025, 4:00 PM

1.420

-0.010 (-0.70%)

Pre-market: May 14, 2025, 7:05 AM EDT

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Neuroscience and Immuno-oncology Drugs	1.38M	Log In
Neuroscience and Immuno-oncology Drugs Growth	268.00%	Log In

Revenue by Geography

Fiscal year is January - December.